About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Healthy Term Infants Fed Milk-Based Formulas | Clinical Trials | Clareo Health

Back to clinical trial search

TERMINATEDNANCT02069522

Healthy Term Infants Fed Milk-Based Formulas

This is a prospective, double blind, crossover study in healthy infants randomized to one of two study formulas. The trial will consist of two 21 day study feeding periods separated by a study washout...

Lead sponsor: Abbott Nutrition•6 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Abbott Nutrition

Age

0 - 0 years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•Infant is in good health
•Infant is a singleton from a full term birth with a gestational age of 37-42 weeks
•Infant's birth weight was \> 2490 g (\~5 lbs 8 oz)
•Infant is between 14 and 28 days of age
•Parent(s) confirm intention to feed their infant the study product(s) as the sole source of nutrition for the duration of the study
•Parent(s) confirm intention not to administer vitamin or mineral supplements, DHA and ARA supplements, solid foods/juices to their infant from enrollment through the duration of the study

Exclusion Criteria

•An adverse maternal, fetal or infant medical history that has potential for effects on tolerance, growth, and/or development.
•Infants using medications (including OTC), home remedies, herbal preparations, probiotics or rehydration fluids that might affect gastrointestinal (GI) tolerance

Related studies

RECRUITINGPhase 4

Duration of Surfactant Administration and Impact on Stabilisation of Vital Parameters in Very Preterm Neonates: 1 Minutes Versus 5 Minutes

NCT07261787 · Neonates and Preterm Infants, Infant Respiratory Distress Syndrome, and more

An Observational Study to Collect Data on How Aflibercept (Eylea) Given Using a Paediatric Dosing Device is Used in Preterm Babies With Retinopathy of Prematurity in the United Kingdom (UK)

NCT06315556 · Retinopathy of Prematurity, Preterm Infants

RECRUITINGPhase 3

Safety and Efficacy of APC-0101 in Preterm Infants With Respiratory Distress Syndrome

NCT06776783 · Respiratory Distress Syndrome, Pre-term Infants

Impact of Parental Training in Endocrine Disruptors on the Excretion of Urinary Biomarkers in Newborns

NCT07349927 · Endocrine Disruptors in Newborns and Infants

NIRS Monitoring in Premature Infants

NCT02601339 · Hemorrhage, Premature Infants, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: March 24, 2015Terms

Trial snapshot

StatusTERMINATED

PhaseNA

Enrollment91

Start dateFeb 2014

Last updatedMar 24, 2015

Condition

Locations shown

Tuscon Medical Center

Tuscon, Arizona

Northpoint Pediatrics

Indianapolis, Indiana

Midwest Children's Health Research Institute

Lincoln, Nebraska

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: March 24, 2015Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions